Skip to main content
. Author manuscript; available in PMC: 2022 Dec 16.
Published in final edited form as: Drug Resist Updat. 2021 Dec 16;59:100796. doi: 10.1016/j.drup.2021.100796

Table 1.

Ras mutations in human cancer. The parentheses indicate the predominant mutations.

Ras isoform Frequency of mutations G12 mutation G13 mutation Q61 mutation Others
KRas 85% 83% (G12D 41%) 14% (G13D 89%) 2% (Q61H 58%) 2%
NRas 11% 23% (G12D 52%) 12% (G13D 50%) 63% (Q61R 47%) 3%
HRas 4% 33% (G12V 57%) 27% (G13R 85%) 37% (Q61R 43%) 3%